2023 IPPOSI Patient Education Programme: Open for Applications
13 February 2023
Are you a patient, patient representative, advocate, or carer? Are you interested in engaging with the research and development process for new medicines, medical devices, and health technologies? Then you should consider applying for the 2023 IPPOSI Patient Education Programme today!
Delivered over 11 months from March 2023 to January 2024, this programme is designed to enable and empower the patient community in Ireland by:
- providing an understanding of the health innovation system and the places for the patient’s voice in it
- teaching patients how to better collaborate with the scientific, medical, and healthcare communities
- developing patients’ confidence and knowledge to speak more effectively on behalf of themselves and those they represent
- facilitating a network of like-minded patients, carers, and advocates
This fourth iteration of the programme is being led by IPPOSI, in partnership with a number of education partners, and will cover the following topics:
- Understanding Clinical Trials – delivered via EUPATI’s Open Classroom platform
- Health Technology Assessment Principles and Practices – delivered by the National Centre for Pharmacoeconomics (NCPE)
- Regulatory Affairs for Medicines and Medical Devices in Europe – delivered by the Health Products Regulatory Authority (HPRA)
All the details you need to complete the application can be viewed here. The information includes a Guide for Applicants, a link to the online application form, and a detailed programme catalogue.
The closing date for applications is 6 March 2023. All further detail can be found here: https://bit.ly/PatientEducation2023
SEE MORE NEWS
SEE MORE NEWS
RCSI Millin Meeting | Friday, 8 November 2024
RCSI Millin Meeting, Friday, 8 November 2024 Click here to confirm your ticket RCSI's prestigious Millin meeting is open to a wide [...]
Autumn Newsletter
Our Autumn 2024 Newsletter is now available! It's jam-packed with news from across the network. Download it here or go to our dedicated [...]